Published in Stroke on September 10, 2009
Statin use and outcome after intracerebral hemorrhage: case-control study and meta-analysis. Neurology (2011) 1.50
Effects of AMP-activated protein kinase in cerebral ischemia. J Cereb Blood Flow Metab (2009) 1.40
Statin treatment and functional outcome after ischemic stroke: case-control and meta-analysis. Stroke (2011) 1.03
White matter hyperintensity burden and susceptibility to cerebral ischemia. Stroke (2010) 0.97
The THRombolysis and STatins (THRaST) study. Neurology (2013) 0.92
Statins and clinical outcome of acute ischemic stroke: a systematic review. Int Arch Med (2010) 0.92
Effect of prior medical treatments on ischemic stroke severity and outcome. Funct Neurol (2011) 0.89
Preexisting statin use is associated with greater reperfusion in hyperacute ischemic stroke. Stroke (2011) 0.86
Multiple biomarker models for improved risk estimation of specific cardiovascular diseases related to metabolic syndrome: a cross-sectional study. Popul Health Metr (2015) 0.85
Statins in Acute Ischemic Stroke: A Systematic Review. J Stroke (2015) 0.83
Effect of previous statin therapy on severity and outcome in ischemic stroke patients: a population-based study. J Neurol (2012) 0.83
Clinical factors associated with statins prescription in acute ischemic stroke patients: findings from the Lombardia Stroke Registry. BMC Neurol (2014) 0.79
A retrospective clinical study of 98 adult idiopathic primary intraventricular hemorrhage cases. Medicine (Baltimore) (2016) 0.78
The effect of statin therapy in stroke outcome: a double blind clinical trial. Int J Prev Med (2012) 0.78
Pathophysiology and Treatments of Oxidative Injury in Ischemic Stroke: Focus on the Phagocytic NADPH Oxidase 2. Antioxid Redox Signal (2014) 0.77
Lipophilic Statins and the Risk of Intracranial Hemorrhage Following Ischemic Stroke: A Population-Based Study. Drug Saf (2017) 0.76
Statin Dose and the Risk of Intracerebral Hemorrhage: A Population-Based Longitudinal Study in Taiwan. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.76
Strategic planning to reduce the burden of stroke among veterans: using simulation modeling to inform decision making. Stroke (2014) 0.76
Effect of pre-stroke statin use on stroke severity and early functional recovery: a retrospective cohort study. BMC Neurol (2015) 0.76
Statins prevent stroke recurrences...but can they improve stroke outcome? Stroke (2009) 0.75
Management of intracerebral hemorrhage-use of statins. Vasc Health Risk Manag (2016) 0.75
Atorvastatin in stroke: a review of SPARCL and subgroup analysis. Vasc Health Risk Manag (2010) 0.75
High doses of statins and stroke outcome. Stroke (2010) 0.75
The efficacy and safety of high-dose statins in acute phase of ischemic stroke and transient ischemic attack: a systematic review. Intern Emerg Med (2017) 0.75
Relationship between pre-stroke cardiovascular medication use and stroke severity. Eur J Clin Pharmacol (2015) 0.75
Low Serum Albumin level as a Predictor of Hemorrhage Transformation after Intravenous Thrombolysis in Ischemic Stroke Patients. Sci Rep (2017) 0.75
High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med (2006) 14.79
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg (2006) 10.79
EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer (1999) 9.68
Genetically elevated C-reactive protein and ischemic vascular disease. N Engl J Med (2008) 7.95
Epidemiological assessment of diet: a comparison of a 7-day diary with a food frequency questionnaire using urinary markers of nitrogen, potassium and sodium. Int J Epidemiol (2001) 4.94
Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24 h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr (1994) 4.32
Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J (2010) 4.31
Lipid treatment assessment project 2: a multinational survey to evaluate the proportion of patients achieving low-density lipoprotein cholesterol goals. Circulation (2009) 3.98
Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospective, randomised trial. Lancet Neurol (2008) 3.91
Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol (2009) 3.88
Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79
Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes. J Am Coll Cardiol (2012) 3.66
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
Relation between maternal haemoglobin concentration and birth weight in different ethnic groups. BMJ (1995) 2.96
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Television viewing and low participation in vigorous recreation are independently associated with obesity and markers of cardiovascular disease risk: EPIC-Norfolk population-based study. Eur J Clin Nutr (2003) 2.68
Residential area deprivation predicts smoking habit independently of individual educational level and occupational social class. A cross sectional study in the Norfolk cohort of the European Investigation into Cancer (EPIC-Norfolk). J Epidemiol Community Health (2003) 2.66
Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke (2007) 2.56
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
Sequence variants on chromosome 9p21.3 confer risk for atherosclerotic stroke. Ann Neurol (2009) 2.55
New England Medical Center Posterior Circulation registry. Ann Neurol (2004) 2.42
Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol (2005) 2.36
European Stroke Initiative Recommendations for Stroke Management-update 2003. Cerebrovasc Dis (2003) 2.35
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology (2003) 2.22
The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr (2007) 2.21
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16
Computed tomography and magnetic resonance perfusion imaging in ischemic stroke: definitions and thresholds. Ann Neurol (2011) 2.15
Implementation and outcome of thrombolysis with alteplase 3-4.5 h after an acute stroke: an updated analysis from SITS-ISTR. Lancet Neurol (2010) 2.12
Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke (2009) 2.10
Validation of weighed records and other methods of dietary assessment using the 24 h urine nitrogen technique and other biological markers. Br J Nutr (1995) 2.07
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ (2010) 1.93
Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology. Neuroepidemiology (2005) 1.92
Standardization of the 24-hour diet recall calibration method used in the european prospective investigation into cancer and nutrition (EPIC): general concepts and preliminary results. Eur J Clin Nutr (2000) 1.92
Yield of systematic transcranial Doppler in patients with transient ischemic attack. Ann Neurol (2010) 1.85
Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 1.81
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain (2005) 1.73
Polymorphism in APOB associated with increased low-density lipoprotein levels in both genders in the general population. J Clin Endocrinol Metab (2005) 1.71
Structure of the standardized computerized 24-h diet recall interview used as reference method in the 22 centers participating in the EPIC project. European Prospective Investigation into Cancer and Nutrition. Comput Methods Programs Biomed (1999) 1.68
Preclinical pharmacology and toxicology of intravenous MV-NIS, an oncolytic measles virus administered with or without cyclophosphamide. Clin Pharmacol Ther (2007) 1.67
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.64
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
Which nerve fibers mediate the axon reflex flare in human skin? Neuroreport (2000) 1.60
Elevated serum ferritin levels predict new-onset type 2 diabetes: results from the EPIC-Norfolk prospective study. Diabetologia (2007) 1.59
Evaluation of under- and overreporting of energy intake in the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 1.58
Gene expression and 18FDG uptake in atherosclerotic carotid plaques. Nucl Med Commun (2010) 1.57
Cigarette smoking and glycaemia: the EPIC-Norfolk Study. European Prospective Investigation into Cancer. Int J Epidemiol (2001) 1.56
Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study. Arch Intern Med (2007) 1.52
Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke (2005) 1.52
Genetically reduced antioxidative protection and increased ischemic heart disease risk: The Copenhagen City Heart Study. Circulation (2003) 1.52
Promotor polymorphisms in leukotriene C4 synthase and risk of ischemic cerebrovascular disease. Arterioscler Thromb Vasc Biol (2008) 1.50
Correlated measurement error--implications for nutritional epidemiology. Int J Epidemiol (2004) 1.49
Blood pressure, risk of ischemic cerebrovascular and ischemic heart disease, and longevity in alpha(1)-antitrypsin deficiency: the Copenhagen City Heart Study. Circulation (2003) 1.48
Fibrillin-1 (FBN1) mutations in patients with thoracic aortic aneurysms. Circulation (1996) 1.47
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet (2011) 1.46
Characterization of carotid artery plaques using real-time compound B-mode ultrasound. Stroke (2004) 1.46
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. J Clin Endocrinol Metab (2008) 1.46
Concurrent dolichoectasia of basilar and coronary arteries. Neurology (2005) 1.44
Aortic arch atheroma in transient ischemic attack patients. Atherosclerosis (2013) 1.43
Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41
The effect of conjugated estrogens/bazedoxifene therapy on body weight of postmenopausal women: pooled analysis of five randomized, placebo-controlled trials. Menopause (2016) 1.40
2001-2011: A Decade of the LADIS (Leukoaraiosis And DISability) Study: What Have We Learned about White Matter Changes and Small-Vessel Disease? Cerebrovasc Dis (2011) 1.40
Area deprivation predicts lung function independently of education and social class. Eur Respir J (2004) 1.37
Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom. Am J Epidemiol (2004) 1.37
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis (2009) 1.36
Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke (2008) 1.36
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke (2010) 1.30
Fruit and vegetable intake and population glycosylated haemoglobin levels: the EPIC-Norfolk Study. Eur J Clin Nutr (2001) 1.29
Vitamin C and hyperglycemia in the European Prospective Investigation into Cancer--Norfolk (EPIC-Norfolk) study: a population-based study. Diabetes Care (2000) 1.28
Age, hypertension, and lacunar stroke are the major determinants of the severity of age-related white matter changes. The LADIS (Leukoaraiosis and Disability in the Elderly) Study. Cerebrovasc Dis (2006) 1.20
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation (2013) 1.20
Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol (2006) 1.18
Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes. Stroke (2009) 1.17
Ischemia-modified albumin in acute stroke. Cerebrovasc Dis (2006) 1.17
Differential impact of cerebral white matter changes, diabetes, hypertension and stroke on cognitive performance among non-disabled elderly. The LADIS study. J Neurol Neurosurg Psychiatry (2007) 1.17
Molecular imaging of human thrombus with novel abciximab immunobubbles and ultrasound. Stroke (2007) 1.16